Market Overview:
Fertility supplements are chemical substances or drugs that stimulate delivery rates and ovulation during fertility levels in women and males. It contains hormones, antioxidants, and other ingredients that can enhance the proper functioning of glands like the hypothalamus and pituitary gland. Currently, certain fertility supplements contain herbal ingredients and are more in demand in the fertility supplements market.
Market Size Growth Rate:
The fertility supplement market was valued at USD 1.72 billion in 2021 and is expected to reach USD 7.54 billion by 2030, and is projected to expand at a CAGR of 7.8% during the forecast period 2023-2030. Due to significant research & development, the launches of new supplements, extensive research, low infertility rate, and favorable reimbursement scenario are anticipated to propel the global fertility supplement market.
Market Drivers:
Rising demand for organic fertility supplements
Now a day consumer demand is on the rise for organic supplements, organic options are available often at higher prices in every category, a change that has seen rapid evolution over the past decade. The awareness is likely to extend from food to supplements, which have a significant necessary part of consumers’ lifestyles. For instance, According to the American society for reproductive medicine, the male partner is responsible for infertility in roughly 40% of infertile couples, and approximately 80%–90% of these couples are treated with pharmaceutical products including fertility supplements products.
In addition, the investment of the government in research on healthcare supplements is also on a rise. Moreover, there is increased government funding for the ingredients required to manufacture organic fertility supplements. All these factors are enhancing the development of the organic fertility supplements segments, and some of the key market players operating in the organic or natural fertility supplement departments are royal cosun, greenyard, himalaya food international ltd., j.r. simplot company, lamb weston holdings, and others.
Market Restraints:
The high price of fertility supplements restrains the market growth
The increasing price of fertility supplements is expected to restrain the growth of the market and rising consumer inclination towards organic products and the limited availability of organic supplements can future hamper the market growth. However, supplement manufacturers are focusing on technological advancement to minimize production costs the make products available for the consumer at affordable prices.
Market Developments:
The majority of the significant fertility supplement market players proactively working to develop potential drug products to improve infertility treatment options.
-
In February 2022, EMD Serono, the healthcare business of Merck KGaA, launched slim pack fertility medication packaging, reduced in size for convenience. This new footprint improves portability, efficiency, and convenience.
-
In March 2022, Dadi (sperm collection as well as testing startup-2019), was acquired by online pharmacy Ro for approximately USD 100 million. With this acquisition, the company expands its presence in the fertility supplement markets
-
In April 2022, Ovaterra by Fertility Nutraceuticals launched two new vitamin supplements. They are parental supplemental capsules formulated with the full recommended daily value of choline for pregnant and nursing women.
Market Segmentation:
As per the research analysis, the global fertility supplements market is segmented by ingredient type into natural, and synthetic/blend of natural & synthetic, by product type into a capsule, tablets, soft gels, powders, and liquids
On the bases of the product type, the capsules segment is one of the most commonly utilized fertility supplements that help in increasing fertility success rate or minimizing infertility issues. These capsule dosages are witnessing high sales due to reducing gastrointestinal irritation, protecting against sensitive ingredients, and their cost-effective nature. Moreover, the powder segment is expected to extensive expand during the forecast period due to increased awareness regarding the nutritional benefits offered by these products and delicious flavors and generally incorporation into meals. These are easily manufactured and come with an affordable price point in numerous developing countries. This is expected to create lucrative growth opportunities for key players.
Geographical Classification:
The global fertility supplements market is segmented into major countries including North America, Europe, South America, Asia Pacific, and the Middle East and Africa.
North America Fertility Supplements Market:
It is expected to witness significant growth over the forecast period due to the increasing infertility rate among people and rising awareness among the population about overall health.
According to the WHO, infertility is a common problem due to various significant factors that influence it, such as increased alcohol and drug use, higher levels of stress (hormonal imbalances), obesity, environmental factors, and frequent smoking among the main causes of the rise in infertility rates, which will fuel the demand for fertility supplements
Europe Fertility Supplements Market:
An aging population and increasing consumer demand for natural supplements lead to healthy products for the rising fertility supplements market. European companies are launching new natural health products, and some are replacing synthetic ingredients with natural ones in product formulations. For instance, Moringa is a plant with a wide range of nutritional properties, powder (leaf) is mainly used in food supplements and mostly plays a key role in balancing hormone levels.
Significantly the western European countries have the major opportunities for exporters of natural ingredients for health products such as vitamins, minerals, traditional medicines, herbal medicines, and supplements in developing countries. In addition, Germany is one of the leading players in the fertility supplements segment, and it is one of the most industrialized countries in the world. However, according to BioMed Central Limited, 5-15% of couples in industrialized countries are infertile. This will increase the demand for natural fertility supplements in the country. However, growing consumer anxiety over the negative side effects of pharmaceutical products is expected to increase the use of supplements, which will benefit product manufacturers.
Competitive Analysis:
However, it is expected to grow rapidly in the next couple of years with intense competition among the players and a rising number of cases. A few key players are already being observed adopting strategies, such as collaboration for the development of therapies and drugs, which may make the market crowded with new products in the next couple of years.
Major Companies:
Major key companies which are contributing to the growth of the market include Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc., PregPrep LLC, Bionova, TTK HealthCare Ltd., Fertility Nutraceuticals LLC, Vitabiotics Ltd., Extreme V, Inc., VH Nutrition LLC, CellOxess LLC, Gonadosan, Amino Expert (Innovamed Ltd.), Babystart Ltd., Crown Nutraceuticals, Sal Nature, YadTech
What we do:
We envision a world where everybody can make the best choices based on trusted information. We are here to assist you in all your market research needs our data & intelligence services to provide in-depth knowledge about new emerging drugs, treatments & diagnostics, and insights on commercial, regulatory, technological, and clinical trial landscapes. We also help in drug pipeline analysis, product commercialization strategy, R&D planning, budgeting, and more.
About Us:
PharmaNucleus is a trusted advisor in the life science & healthcare market. Our mission is to help our clients with real-time, accurate, and reliable information from the industry.
Contact Us:
Name:
Company Address:
Contact no:
Email:
Website: http://www.pharmanucleus.com/
Source: PharmaNucleus